Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 858 results for "astrazeneca"

Lilly, AstraZeneca in Alzheimer\\'s R&D Alliance
Contract Pharma

Astrazeneca, Lilly ink pact to co-develop second potentially d...

AstraZeneca and Eli Lilly and Company announced a worldwide agreement to co-develop MEDI1814, an antibody selective for amyloid-beta 42 (Aß42), which is currently in phase I trials as a potential disease-modifying treatment for Alzheimer's disease ... PharmaBiz, 15 minutes ago

900 images for astrazeneca

American Banking News, 14 hours ago
PharmaVOICE, 9 hours ago
SleekMoney, 14 hours ago
American Banking News, 1 day ago
Yahoo! News, 10 hours ago
Proactive Investors USA, 5 hours ago
Yahoo! Singapore, 14 hours ago
Reuters, 10 hours ago
WKRB News, 2 days ago, 10 hours ago
Yahoo! Finance

How AstraZeneca plc (ADR) (AZN) Stacks Up Against Its Peers

More At Insider Monkey we track the activity of some of the best-performing hedge funds like Appaloosa Management, Baupost, and Third Point because we determined that some of the stocks that they are collectively bullish on can help us generate ...
 Yahoo! Finance1 hour ago AstraZeneca PLC (ADR) (AZN) Cuts Jobs, Signs New Collaboration With Eli Lilly And Co (LLY)  Yahoo! Finance12 hours ago ASTRAZENECA PLC (NYSE : AZN) Cuts Jobs, Signs New Collaboration With Eli Lilly and Co (NYSE:LLY)  4 Traders14 hours ago EPS Forecast At $0.57 For Astrazeneca PLC (NYSE:AZN)  Markets Daily5 days ago
Proactive Investors USA

FDA accepts AstraZeneca's marketing application for durvalumab for bladder cancer; shares up 4%

The FDA accepts under Priority Review AstraZeneca's ( AZN +3.7%) Biologics License Application (BLA) seeking approval of durvalumab for the treatment of patients with locally advanced or metastatic urothelial carcinoma whose disease has progressed ...
 Seeking Alpha10 hours ago BRIEF-Astrazeneca says durvalumab gets FDA's priority review status in bladder cancer  Reuters UK12 hours ago FDA Accepts First BLA For Astrazeneca's Durvalumab In Bladder Cancer  RTTNews.com12 hours ago TOP NEWS: AstraZeneca Receives FDA Priority Status For Durvalumab  London Stock Exchange12 hours ago

AstraZeneca to cut 700 jobs across USA

, that it will eliminate 700 positions across the United States. Here, the company's U.S. headquarters in Fairfax, Del.(Photo: Provided by AstraZeneca via The (Wilmington, Del.) News Journal) WILMINGTON, Del. — Pharmaceutical company AstraZeneca ...
 USA Today1 day ago AstraZeneca cuts about 700 jobs, including 120 in Delaware  Washington Post1 day ago AstraZeneca PLC to Eliminate 700 U.S. Jobs  BioSpace15 hours ago AZ to chop 700 U.S. jobs, making pharma's bad jobs week worse  FiercePharma1 day ago

Asia and Australasia Influenza Vaccines Market to Reach $1.5 Billion by 2021 - Key Vendors are AstraZeneca, Novartis & Pfizer - Research and Markets

Research and Markets has announced the addition of the "Asia and Australasia Influenza Vaccines Market, Persons Vaccinated, Brand Analysis and Forecast to 2021" report to their offering. The Asia and Australasia influenza vaccines market is ...
 4 Traders16 hours ago RESEARCHERS FROM ASTRAZENECA REPORT NEW STUDIES AND FINDINGS IN THE AREA OF DRUG DEVELOPMENT (THERAPEUTIC POTENTIAL OF FOLDAMERS : From Chemical...  4 Traders1 day ago Global Peptide Therapeutics Market 2016 Amgen, Roche, Sanofi, Lonza, Novartis, AstraZeneca  Digital Journal1 week ago Astrazeneca Pharma India reports standalone net profit of Rs 0.79 crore in the September 2016 quarter  Business Standard4 weeks ago
Reuters UK

AstraZeneca's immunotherapy enters U.S. approval process

FRANKFURT AstraZeneca's immunotherapy drug durvalumab, the British drugmaker's most important pipeline medicine, has been accepted for review by U.S. regulators against bladder cancer, potentially its first use. The U.S. Food and Drug ...
 Reuters UK10 hours ago Astra, Lilly stick with Alzheimer's approach despite setback  Yahoo! Finance UK and Ireland14 hours ago

AstraZeneca Higher Off Drug News And Upgrade

AstraZeneca plc (ADR) (NYSE: AZN ) shares are trading higher by $1.00 at $27.28 in Friday's session. The primary catalyst for the rally is the announcement that the FDA has accepted duravalumab for priority review status. Also, before the open, ...
 Benzinga.com11 hours ago PARK CIRCLE Co Maintains Stake in Astrazeneca PLC (AZN)  WKRB News2 days ago MSI Financial Services Inc Sells 177 Shares of Astrazeneca PLC (AZN)  SleekMoney5 days ago Toronto Dominion Bank Maintains Position in Astrazeneca PLC (AZN)  Mideast Time6 days ago

Trading in AstraZeneca halted pending news

ading in AstraZeneca (AZN +3.2%) was halted about five minutes ago pending news. Now read: Snippet Roundup: Deals For Boston And Astra; Data For Novo; An Approval For Biosurfit » From other sites Good, bad, ugly: BOBE, AZN & HRB Video at ...
 Seeking Alpha12 hours ago

Broadcom, Finisar Price Targets Hiked; Astrazeneca A Top Pick

More Broadcom and Finisar got price-target hikes after beating earnings estimates late Thursday, while Astrazeneca got
 Yahoo! Finance13 hours ago

Analysts' Actions -- Autodesk, Aflac, AstraZeneca, Duluth and More

 TheStreet.com14 hours ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less